Colesevelam Hydrochloride

CHEMBL1201473 Phase 4 Одобрено Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

The hydrochloride salt formulation of colesevelam, a non-absorbed bile acid–binding resin used to reduce LDL cholesterol and improve glycemic control in type 2 diabetes. It is taken with meals and does not enter systemic circulation.

Терапевтические области

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

The hydrochloride salt formulation of colesevelam, a non-absorbed bile acid–binding resin used to reduce LDL cholesterol and improve glycemic control in type 2 diabetes. It is taken with meals and does not enter systemic circulation.

Yes, Colesevelam Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201473. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.